LPL Financial
SANA icon

LPL Financial’s Sana Biotechnology SANA Stock Holding History

LPL Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
31,533
+11,721
+59% +$37.8K ﹤0.01% 5900
2026
Q1 		$57.1K Sell
19,812
-5,863
-23% -$23.1K ﹤0.01% 5761
2025
Q4 		$104K Buy
+25,675
New +$115K ﹤0.01% 5586
2025
Q1 		– Sell
-13,140
Closed -$21.4K – 5491
2024
Q4 		$21.4K Sell
13,140
-11,100
-46% -$33.1K ﹤0.01% 5194
2024
Q3 		$101K Buy
24,240
+200
+0.8% +$1.05K ﹤0.01% 4889
2024
Q2 		$131K Sell
24,040
-885
-4% -$7.05K ﹤0.01% 4680
2024
Q1 		$249K Buy
24,925
+2,450
+11% +$18.4K ﹤0.01% 4349
2023
Q4 		$91.7K Buy
22,475
+2,150
+11% +$7.92K ﹤0.01% 4568
2023
Q3 		$78.7K Sell
20,325
-300
-1% -$1.61K ﹤0.01% 4459
2023
Q2 		$123K Buy
+20,625
New +$119K ﹤0.01% 4284
2022
Q2 		– Sell
-12,330
Closed -$102K – 4521
2022
Q1 		$102K Buy
+12,330
New +$99.7K ﹤0.01% 3977

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

LPL Financial's SANA Position: Q2 2026 in Review

LPL Financial increased its Sana Biotechnology (SANA) stake by 59% in Q2 2026, buying an estimated $37.8K and bringing the position to 31,533 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5900.

LPL Financial first reported a position in SANA in Q1 2022 and has held it in 11 quarters since. The position peaked at $249K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • LPL Financial held 31,533 shares of Sana Biotechnology worth $110K as of Q2 2026.
  • LPL Financial bought 11,721 Sana Biotechnology shares in Q2 2026, an estimated $37.8K.
  • Sana Biotechnology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5900 holding.
  • LPL Financial first reported a position in Sana Biotechnology in Q1 2022 and has held it in 11 quarters since.
  • LPL Financial's Sana Biotechnology position peaked at $249K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.